The MRSA antibiotic market is expected to grow at a significant CAGR of 5.5% during the forecast period. The increase in the MRSA infections and a rise in the immuno-compromised population are expected to enhance the market growth. According to the information highlighted by the centers for diseases control and prevention (CDC), in 2019, 2% of the general population carries MRSA. Moreover, As per the findings from a six-month, hospital-based observational study provided by the American Journal of Infection Control (AJIC), in August 2021, new data suggest that methicillin-resistant Staphylococcus aureus (MRSA) is frequently shed during outpatient healthcare visits, creating the potential for transmission to other patients and healthcare staff. This is considered as the first empirical data regarding the frequency of and risk factors for MRSA contamination outside hospital rooms.
Get Free Sample link @ https://www.omrglobal.com/request-sample/mrsa-antibiotic-market
Further, MRSA antibiotics have been gaining significant growth in recent years owing to the rising awareness about MRSA infection. For instance, globally MRSA awareness day is celebrated in October and antibiotic awareness day on November 18 in Europe. Additionally, the MRSA antibiotic market fragmented with players such as Pfizer, Lilly, Sanofi Aventis, and Merck that are contributing significantly to the market.
A full report of Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotic Market available @ https://www.omrglobal.com/industry-reports/mrsa-antibiotic-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global MRSA Antibiotic Market by Treatment Type
- Vancomycin
- Tetracycline
- Linezolid
- Daptomycin
- Lipopeptide
Global MRSA Antibiotic Market by Distribution Channel
- Online
- Hospital Pharmacies
- Retail Pharmacies
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Allergan Inc.
- Baxter International Inc.
- Cumberland Pharmaceuticals Inc.
- Debiopharm International
- Fresenius Kabi AG
- Innovation Pharmaceuticals Inc.
- Melinta therapeutics Inc.
- Nabriva Therapeutics Plc.
- North China Pharmaceutical Group Corp.
- Novartis International AG
- Paratek Pharmaceuticals Inc.
- Sanofi-Aventis Groupe
- Teva Pharmaceutical Industries Ltd.
- Theravance Biopharma Inc.
- Xellia Pharmaceuticals ApS
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Medicine Co., Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global MRSA antibiotic market. Based on the availability of data, information related to market, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/mrsa-antibiotic-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
